These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19351740)

  • 21. Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies.
    Dirksen MT; Laarman GJ; Simoons ML; Duncker DJ
    Cardiovasc Res; 2007 Jun; 74(3):343-55. PubMed ID: 17306241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS; Krolikowski JG
    Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Protecting vascular integrity in acute myocardial ischemia-reperfusion].
    Galaup A; Germain S
    Med Sci (Paris); 2012 Feb; 28(2):133-5. PubMed ID: 22377295
    [No Abstract]   [Full Text] [Related]  

  • 24. Protection against myocardial ischemia-reperfusion injury in clinical practice.
    Garcia-Dorado D; Rodríguez-Sinovas A; Ruiz-Meana M; Inserte J
    Rev Esp Cardiol (Engl Ed); 2014 May; 67(5):394-404. PubMed ID: 24774733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathophysiology of myocardial reperfusion injury].
    Piper HM; Kasseckert SA; Schlüter KD; Abdallah Y
    Dtsch Med Wochenschr; 2008 Mar; 133(12):586-90. PubMed ID: 18335390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The biochemical and cellular bases of myocardial ischemia-reperfusion damage].
    Téllez F; Carvajal K; García C; Vásquez C; Chávez E; Moreno-Sánchez R
    Arch Inst Cardiol Mex; 1996; 66(2):162-81. PubMed ID: 8768635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remote Ischemic Conditioning for Patients With STEMI.
    Schmidt MR; Rasmussen ME; Bøtker HE
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):302-309. PubMed ID: 28381115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The targeting of cyclophilin D by RNAi as a novel cardioprotective therapy: evidence from two-photon imaging.
    Kato M; Akao M; Matsumoto-Ida M; Makiyama T; Iguchi M; Takeda T; Shimizu S; Kita T
    Cardiovasc Res; 2009 Jul; 83(2):335-44. PubMed ID: 19299432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New pharmacologic options in the treatment of acute coronary syndromes and myocardial ischemia-reperfusion injury: potential role of levosimendan.
    Garcia-Gonzalez MJ; Dominguez-Rodriguez A; Abreu-Gonzalez P
    Minerva Cardioangiol; 2007 Oct; 55(5):625-35. PubMed ID: 17912166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postconditioning: from experimental proof to clinical concept.
    Mewton N; Ivanès F; Cour M; Ovize M
    Dis Model Mech; 2010; 3(1-2):39-44. PubMed ID: 20075381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of cytochrome c on the myocardium during reperfusion].
    Boiarinov GA; Iakovlev AIu; Teziaeva SA; Mukhina IV; Boiarinova LV
    Patol Fiziol Eksp Ter; 1999; (4):20-5. PubMed ID: 10598459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial protection: is primary PCI enough?
    Hausenloy DJ; Yellon DM
    Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):12-3. PubMed ID: 18852713
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacological targets revealed by myocardial postconditioning.
    Burley DS; Baxter GF
    Curr Opin Pharmacol; 2009 Apr; 9(2):177-88. PubMed ID: 19109069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia-reperfusion injury.
    Ruiz-Meana M; Rodríguez-Sinovas A; Cabestrero A; Boengler K; Heusch G; Garcia-Dorado D
    Cardiovasc Res; 2008 Jan; 77(2):325-33. PubMed ID: 18006437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier.
    Ndrepepa G; Colleran R; Kastrati A
    Coron Artery Dis; 2017 May; 28(3):253-262. PubMed ID: 28072597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reperfusion injury: doublethink or misnomer.
    Sobel BE; Zaman AK
    Coron Artery Dis; 2011 Nov; 22(7):515-7. PubMed ID: 21849893
    [No Abstract]   [Full Text] [Related]  

  • 37. PPAR-γ and AMPK--advantageous targets for myocardial ischemia/reperfusion therapy.
    Morrison A; Li J
    Biochem Pharmacol; 2011 Aug; 82(3):195-200. PubMed ID: 21536015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of calpains to myocardial ischaemia/reperfusion injury.
    Inserte J; Hernando V; Garcia-Dorado D
    Cardiovasc Res; 2012 Oct; 96(1):23-31. PubMed ID: 22787134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. (S)-1-(alpha-naphthylmethyl)-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (CKD712) reduces rat myocardial apoptosis against ischemia and reperfusion injury by activation of phosphatidylinositol 3-kinase/Akt signaling and anti-inflammatory action in vivo.
    Jin YC; Lee YS; Kim YM; Seo HG; Lee JH; Kim HJ; Yun-Choi HS; Chang KC
    J Pharmacol Exp Ther; 2009 Aug; 330(2):440-8. PubMed ID: 19458286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to: Effect of inhibition of Na(+)/Ca(+) exchanger at the time of myocardial reperfusion on hypercontracture and cell death.
    Anderson S
    Cardiovasc Res; 2002 Sep; 55(4):706-7. PubMed ID: 12176118
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.